{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T04:36:28Z","timestamp":1782880588215,"version":"3.54.5"},"reference-count":39,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Science Centre for Medical University of Lodz","award":["2011\/01\/B\/NZ4\/04903"],"award-info":[{"award-number":["2011\/01\/B\/NZ4\/04903"]}]}],"content-domain":{"domain":["clinicalkey.jp","schres-journal.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.schres.2016.07.010","type":"journal-article","created":{"date-parts":[[2016,7,21]],"date-time":"2016-07-21T18:04:58Z","timestamp":1469124298000},"page":"245-251","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Antioxidant properties of atypical antipsychotic drugs used in the treatment of schizophrenia"],"prefix":"10.1016","volume":"176","author":[{"given":"Izabela","family":"Sadowska-Bartosz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabina","family":"Galiniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grzegorz","family":"Bartosz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariusz","family":"Zuberek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Grzelak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Dietrich-Muszalska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.schres.2016.07.010_bb0005","first-page":"75","article-title":"Does clozapine induce myocarditis, myocardial oxidative stress and DNA damage in rats? Egypt","volume":"4","author":"Abdel-Wahab","year":"2014","journal-title":"J. Forens. Sci."},{"issue":"1","key":"10.1016\/j.schres.2016.07.010_bb0010","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000202823","article-title":"Potential effect of olanzapine on total antioxidant status and lipid peroxidation in schizophrenic patients","volume":"59","author":"Al-Chalabi","year":"2009","journal-title":"Neuropsychobiology"},{"issue":"5","key":"10.1016\/j.schres.2016.07.010_bb0015","first-page":"273","article-title":"Biochemical effects of chlorpromazine on mouse neuroblastoma cells","volume":"41","author":"Andres","year":"1999","journal-title":"Vet. Hum. Toxicol."},{"key":"10.1016\/j.schres.2016.07.010_bb0020","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0065-2423(03)37010-6","article-title":"Total antioxidant capacity","volume":"37","author":"Bartosz","year":"2003","journal-title":"Adv. Clin. Chem."},{"issue":"4","key":"10.1016\/j.schres.2016.07.010_bb0025","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/sj.npp.1300911","article-title":"Antipsychotic drugs inhibit the human corticotropin-releasing-hormone gene promoter activity in neuro-2A cells-an involvement of protein kinases","volume":"31","author":"Basta-Kaim","year":"2006","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.schres.2016.07.010_bb0035","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1006\/abio.1996.0292","article-title":"The ferric reducing ability of plasma (FRAP) as a measure of \u201cantioxidant power\u201d: the FRAP assay","volume":"239","author":"Benzie","year":"1996","journal-title":"Anal. Biochem."},{"issue":"2","key":"10.1016\/j.schres.2016.07.010_bb0040","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2174\/157015911795596504","article-title":"Schizophrenia: redox regulation and volume neurotransmission","volume":"9","author":"B\u00f3kkon","year":"2011","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.schres.2016.07.010_bb0045","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.biopha.2016.02.047","article-title":"Clozapine and olanzapine are better antioxidants than haloperidol, quetiapine, risperidone and ziprasidone in in vitro models","volume":"81","author":"Brinholi","year":"2016","journal-title":"Biomed. Pharmacother."},{"issue":"6","key":"10.1016\/j.schres.2016.07.010_bb0050","first-page":"711","article-title":"Effect of antidepressant drugs on the human corticotropin-releasing-hormone gene promoter activity in neuro-2A cells","volume":"54","author":"Budziszewska","year":"2002","journal-title":"Pol. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.schres.2016.07.010_bb0055","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the Chou-Talalay method","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.schres.2016.07.010_bb0060","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/10715769800300171","article-title":"Antioxidant properties of clozapine and related neuroleptics","volume":"29","author":"Dalla Libera","year":"1998","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.schres.2016.07.010_bb0065","series-title":"Studies on Psychiatric Disorders","first-page":"299","article-title":"The role of nitric oxide and nitrosative stress in schizophrenia. 2015.","author":"Dietrich-Muszalska","year":"2015"},{"issue":"4","key":"10.1016\/j.schres.2016.07.010_bb0075","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3109\/00498254.2015.1078522","article-title":"Involvement of oxidative stress and mitochondrial\/lysosomal cross-talk in olanzapine cytotoxicity in freshly isolated rat hepatocytes","volume":"46","author":"Eftekhari","year":"2016","journal-title":"Xenobiotica"},{"issue":"1","key":"10.1016\/j.schres.2016.07.010_bb0080","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0003-9861(59)90090-6","article-title":"Tissue sulfhydryl groups","volume":"82","author":"Ellman","year":"1959","journal-title":"Arch. Biochem. Biophys."},{"issue":"4","key":"10.1016\/j.schres.2016.07.010_bb0085","first-page":"1","article-title":"Comparison of the antioxidant potential of antiparkinsonian drugs in different in vitro models","volume":"50","author":"Faria","year":"2014","journal-title":"Braz. J. Pharm. Sci."},{"key":"10.1016\/j.schres.2016.07.010_bb0090","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.freeradbiomed.2013.05.045","article-title":"How do nutritional antioxidants really work: nucleophilic tone and para-hormesis versus free radical scavenging in vivo","volume":"66","author":"Forman","year":"2014","journal-title":"Free Radic. Biol. Med."},{"issue":"3","key":"10.1016\/j.schres.2016.07.010_bb0095","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1472-8206.1997.tb00195.x","article-title":"Metabolism of clozapine by human neutrophils: evidence for a specific oxidation of clozapine by the myeloperoxidase system with inhibition of enzymatic chlorination cycle","volume":"11","author":"Frimat","year":"1997","journal-title":"Fundam. Clin. Pharmacol."},{"issue":"6","key":"10.1016\/j.schres.2016.07.010_bb0100","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0026-895X(24)13268-3","article-title":"A comparison of the oxidation of clozapine and olanzapine to reactive metabolites and the toxicity of these metabolites to human leukocytes","volume":"53","author":"Gardner","year":"1998","journal-title":"Mol. Pharmacol."},{"issue":"3","key":"10.1016\/j.schres.2016.07.010_bb0110","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1080\/003655102317475498","article-title":"Assay of total antioxidant capacity: comparison of four methods as applied to human blood plasma","volume":"62","author":"Janaszewska","year":"2002","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.schres.2016.07.010_bb0115","doi-asserted-by":"crossref","first-page":"828702","DOI":"10.1155\/2014\/828702","article-title":"Lipid peroxidation in psychiatric illness: overview of clinical evidence","volume":"2014","author":"Joshi","year":"2014","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"11","key":"10.1016\/j.schres.2016.07.010_bb0120","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S0006-3223(01)01251-3","article-title":"Dopamine D(2) receptors and their role in atypical antipsychotic action: still necessary and may even be sufficient","volume":"50","author":"Kapur","year":"2001","journal-title":"Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2016.07.010_bb0125","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1124\/jpet.102.046987","article-title":"Antipsychotic dosing in preclinical models is often unrepresentative of the clinical condition: a suggested solution based on in vivo occupancy","volume":"305","author":"Kapur","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2\u20133","key":"10.1016\/j.schres.2016.07.010_bb0130","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.schres.2011.03.019","article-title":"Aripiprazole inhibits superoxide generation from phorbol-myristate-acetate (PMA)-stimulated microglia in vitro: implication for antioxidative psychotropic actions via microglia","volume":"129","author":"Kato","year":"2011","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2016.07.010_bb0135","first-page":"69","article-title":"Neuroblastoma: cell culture analysis of a differentiating stem cell system","volume":"43","author":"Klebe","year":"1969","journal-title":"J. Cell Biol."},{"issue":"1","key":"10.1016\/j.schres.2016.07.010_bb0140","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.schres.2015.06.022","article-title":"Implications for reactive oxygen species in schizophrenia pathogenesis","volume":"176","author":"Koga","year":"2016","journal-title":"Schizophr. Res."},{"issue":"Suppl. 2","key":"10.1016\/j.schres.2016.07.010_bb0145","first-page":"175","article-title":"The impact of clozapine on regulation of inflammation in murine macrophage cells","volume":"35","author":"Kracmarova","year":"2014","journal-title":"Neuroendocrinol. Lett."},{"issue":"1","key":"10.1016\/j.schres.2016.07.010_bb0150","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1615\/CritRevNeurobiol.v17.i1.20","article-title":"On the use of neuro-2a neuroblastoma cells versus intact neurons in primary culture for neurotoxicity studies","volume":"17","author":"LePage","year":"2005","journal-title":"Crit. Rev. Neurobiol."},{"key":"10.1016\/j.schres.2016.07.010_bb0155","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.brainres.2009.05.063","article-title":"Clozapine protects PC-12 cells from death due to oxidative stress induced by hydrogen peroxide via a cell-type specific mechanism involving inhibition of extracellular signal-regulated kinase phosphorylation","volume":"1283","author":"Magliaro","year":"2009","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.schres.2016.07.010_bb0160","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.coph.2011.02.007","article-title":"The role of serotonin receptors in the action of atypical antipsychotic drugs","volume":"11","author":"Meltzer","year":"2011","journal-title":"Curr. Opin. Pharmacol."},{"issue":"1","key":"10.1016\/j.schres.2016.07.010_bb0165","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1073\/pnas.65.1.129","article-title":"Isolation of microtubule protein from cultured mouse neuroblastoma cells","volume":"65","author":"Olmsted","year":"1970","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.schres.2016.07.010_bb0170","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.neulet.2010.05.088","article-title":"Evaluation of antioxidant enzymes activities and lipid peroxidation in schizophrenic patients treated with typical and atypical antipsychotics","volume":"479","author":"Padurariu","year":"2010","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.schres.2016.07.010_bb0175","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0022-3956(02)00048-1","article-title":"Differential effects of antipsychotics on expression of antioxidant enzymes and membrane lipid peroxidation in rat brain","volume":"37","author":"Parikh","year":"2003","journal-title":"J. Psychiatr. Res."},{"issue":"4","key":"10.1016\/j.schres.2016.07.010_bb0180","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.neures.2011.01.004","article-title":"Protective effects of atypical antipsychotic drugs against MPP+-induced oxidative stress in PC12 cells","volume":"69","author":"Park","year":"2011","journal-title":"Neurosci. Res."},{"issue":"3","key":"10.1016\/j.schres.2016.07.010_bb0185","doi-asserted-by":"crossref","first-page":"166","DOI":"10.18632\/aging.100131","article-title":"Interpretation and applicability of microRNA data to the context of Alzheimer's and age-related diseases","volume":"2","author":"Provost","year":"2010","journal-title":"Aging (Albany NY)"},{"issue":"1","key":"10.1016\/j.schres.2016.07.010_bb0190","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0891-5849(94)00105-S","article-title":"A practical method for preparing peroxynitrite solutions of low ionic strength and free of hydrogen peroxide","volume":"18","author":"Pryor","year":"1995","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.schres.2016.07.010_bb0195","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.freeradbiomed.2015.11.002","article-title":"Nitroxides protect against peroxynitrite-induced nitration and oxidation","volume":"89","author":"Sadowska-Bartosz","year":"2015","journal-title":"Free Radic. Biol. Med."},{"issue":"3","key":"10.1016\/j.schres.2016.07.010_bb0200","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/jnr.10668","article-title":"Olanzapine protects PC12 cells from oxidative stress induced by hydrogen peroxide","volume":"73","author":"Wei","year":"2003","journal-title":"J. Neurosci. Res."},{"issue":"6","key":"10.1016\/j.schres.2016.07.010_bb0205","doi-asserted-by":"crossref","first-page":"795e","DOI":"10.1002\/jnr.23360","article-title":"Neuroprotection of posttreatment with risperidone, an atypical antipsychotic drug, in rat and gerbil models of ischemic stroke and the maintenance of antioxidants in a gerbil model of ischemic stroke","volume":"92","author":"Yan","year":"2014","journal-title":"J. Neurosci. Res."},{"issue":"5\u20136","key":"10.1016\/j.schres.2016.07.010_bb0210","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1016\/j.neuropharm.2011.12.014","article-title":"Effects of risperidone and haloperidol on superoxide dismutase and nitric oxide in schizophrenia","volume":"62","author":"Zhang","year":"2012","journal-title":"Neuropharmacology"}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996416303267?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996416303267?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T03:46:03Z","timestamp":1749008763000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996416303267"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":39,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S0920996416303267"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2016.07.010","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antioxidant properties of atypical antipsychotic drugs used in the treatment of schizophrenia","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2016.07.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}